Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption
In December 2019, the 2019 novel coronavirus disease (COVID-19), which has been identified to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China and spread across the world. Higher plasma levels of cytokines, including interleukin (IL)-6, IL-2, IL-7, IL-10, a...
Main Authors: | Yinke Du, Zhipeng Qi, Jiangwei Ma, Da Sun, Li Yao, Bin Xu, Wei Liu, Zhaofa Xu, Yu Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.607849/full |
Similar Items
-
The pandemic characteristics of 2019-nCoV: case-control study for severity and geographic locations for 2019-nCoV epidemics worldwide
by: Roberto Ronchetti, et al.
Published: (2020-07-01) -
The novel coronavirus outbreak: what can be learned from China in public reporting?
by: Hao Li, et al.
Published: (2020-03-01) -
Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2
by: Neha Sami, et al.
Published: (2021-03-01) -
Complicated appendicitis are common during the epidemic period of 2019 novel coronavirus (2019-nCoV)
by: Zhiguang Gao, et al.
Published: (2020-10-01) -
Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China
by: Zhanwei Du, et al.
Published: (2020-05-01)